Zhou, Bojun
Wu, Dongzhe
Chen, Shuting
Zhang, Shiyan
Ge, Xiaochuan
Li, Jiaming
Zhu, Lianghao
Zhou, Shijie
Chang, Ninghao
Zhou, Biao
Zhang, Lei
Meng, Hua
Clinical trials referenced in this document:
Documents that mention this clinical trial
Body mass index, physical activity, and epigenetic aging: a cross-population study
https://doi.org/10.1186/s13148-026-02149-2
Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections
https://doi.org/10.1055/a-2793-9945
Funding for this research was provided by:
National Natural Science Foundation of China (82470857)
Beijing Natural Science Foundation (7242125)
Article History
Received: 24 January 2026
Accepted: 22 April 2026
First Online: 8 May 2026
Declarations
:
: All the cohorts and samples involved in the study adhered to national and international guidelines, including the Deontological Code and the Declaration of Helsinki, and complied with current personal data protection regulations. The research using publicly available data was approved by the relevant authorities, with all participants having provided informed consent. For the multi-biomarker studies, ethical approval was obtained from China-Japan Friendship Hospital and Beijing Sport University, and all participants signed informed consent forms (Ethics approval number: 2021-112-K70).
: Written informed consent for publication was obtained from every patient; for minors, consent was secured from their parents or legal guardians.
: The authors declare no competing interests.